Detalhe da pesquisa
1.
Fibroblast growth factor receptor 1 inhibition suppresses pancreatic cancer chemoresistance and chemotherapy-driven aggressiveness.
Drug Resist Updat
; 73: 101064, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38387284
2.
The role of microbiome in pancreatic cancer.
Cancer Metastasis Rev
; 40(3): 777-789, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34455517
3.
Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer.
Ann Surg Oncol
; 29(3): 1579-1591, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34724125
4.
FDG-PET Predicts Neoadjuvant Therapy Response and Survival in Borderline Resectable/Locally Advanced Pancreatic Adenocarcinoma.
J Natl Compr Canc Netw
; 20(9): 1023-1032.e3, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36075389
5.
A phase I study of the anaplastic lymphoma kinase inhibitor ceritinib in combination with gemcitabine-based chemotherapy in patients with advanced solid tumors.
Int J Cancer
; 149(12): 2063-2074, 2021 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34319586
6.
Synergistic Pharmacodynamic Effects of Gemcitabine and Fibroblast Growth Factor Receptor Inhibitors on Pancreatic Cancer Cell Cycle Kinetics and Proliferation.
J Pharmacol Exp Ther
; 377(3): 370-384, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33753538
7.
Nanoliposomal irinotecan (Nal-IRI)-based chemotherapy after irinotecan -based chemotherapy in patients with pancreas cancer.
Pancreatology
; 21(2): 379-383, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33468394
8.
Homologous Recombination Repair Defect May Predict Treatment Response to Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors.
Oncologist
; 25(8): e1246-e1248, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32510802
9.
Role of Surgery and Perioperative Therapy in Older Patients with Resectable Pancreatic Ductal Adenocarcinoma.
Oncologist
; 25(11): e1681-e1690, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32663355
10.
Emergency use of uridine triacetate for the prevention and treatment of life-threatening 5-fluorouracil and capecitabine toxicity.
Cancer
; 123(2): 345-356, 2017 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27622829
11.
Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer.
Br J Cancer
; 115(2): 188-94, 2016 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27351217
12.
Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine.
N Engl J Med
; 369(18): 1691-703, 2013 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-24131140
13.
A first-in-human phase I study to evaluate the MEK1/2 inhibitor, cobimetinib, administered daily in patients with advanced solid tumors.
Invest New Drugs
; 34(5): 604-13, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27424159
14.
A phase I study of the histone deacetylase (HDAC) inhibitor entinostat, in combination with sorafenib in patients with advanced solid tumors.
Invest New Drugs
; 33(1): 225-32, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25371323
15.
Phase 1b study of the oral gemcitabine 'Pro-drug' LY2334737 in combination with capecitabine in patients with advanced solid tumors.
Invest New Drugs
; 33(2): 432-9, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25640850
16.
Phase 1 trial of tivantinib in combination with sorafenib in adult patients with advanced solid tumors.
Invest New Drugs
; 33(1): 159-68, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25294187
17.
Effects of low-fat and high-fat meals on steady-state pharmacokinetics of lapatinib in patients with advanced solid tumours.
Invest New Drugs
; 32(3): 481-8, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24346280
18.
Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines.
J Natl Compr Canc Netw
; 12(8): 1083-93, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25099441
19.
Expression of fibroblast growth factor receptor 1 correlates inversely with the efficacy of single-agent fibroblast growth factor receptor-specific inhibitors in pancreatic cancer.
Br J Pharmacol
; 181(9): 1383-1403, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37994108
20.
Microfluidic Organoid Cultures Derived from Pancreatic Cancer Biopsies for Personalized Testing of Chemotherapy and Immunotherapy.
Adv Sci (Weinh)
; 11(5): e2303088, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38018486